Back to bills
Next GEN Act of 2026
Last updated: 5/15/2026 · Introduced: 5/15/2026
Author: Joseph Morelle (D-NY)
TL;DR (AI)
- The bill extends the exclusivity period for engineered cyclic peptides to 11 years under the Drug Price Negotiation Program.
- It defines 'engineered cyclic peptide' based on specific compositional and developmental criteria.
- This legislation modifies rules for engineered cyclic peptides applicable to drug lists published on or after the bill's enactment.
Verified Votes
No verified votes yet.
Community Votes
No community votes yet. Be the first!
Voting as guest · Sign in for verified votes
Other Sections
Includes provisions on preamble, short title., and 1 more.
3 sections
Click "Show details" to explore individual sections. Use the community vote above or visit All Sections to vote per section.
Want the full experience?
Create a free account to cast verified votes on each section, get a personalized summary, and track your voting history.
Create Free Account